Jennifer Auble

Jennifer Auble serves as a key procurement professional within the General Services Administration’s Federal Acquisition Service, specifically supporting the FAS AAS FedSim division. She manages the acquisition of mission-critical professional, technical, and logistics services essential to national infrastructure and defense readiness, with a focus on IT modernization, emergency relief operations, and scientific research and development. Her work ensures the timely delivery of scalable, secure capabilities that sustain federal operational continuity, particularly in high-stakes environments requiring rapid response and technical precision. She oversees complex contract vehicles including Indefinite-Delivery, Indefinite-Quantity (IDIQ) and Other Transaction Authority (OTA) instruments to meet urgent and evolving agency needs. Auble cultivates strategic relationships with a broad spectrum of vendors, including established federal contractors and specialized firms with domain expertise in emergency response systems and physical sciences R&D. While no single contractor dominates her portfolio, she consistently engages firms capable of delivering integrated solutions across logistics, cybersecurity, and operational support domains. Her contracting patterns reflect a preference for performance-based outcomes, emphasizing flexibility, innovation, and rapid deployment capabilities. Auble’s procurement strategy is entirely non-set-aside, with 100% of acquisitions conducted under full and open competition. This reflects a deliberate focus on maximizing technical capability and operational readiness over socioeconomic preferences, prioritizing mission outcomes above certification-based set-asides such as 8(a), HUBZone, or SDVOSB programs. Her primary procurement focus centers on NAICS 624230 for emergency and relief services and NAICS 541715 for physical and engineering research and development. She routinely acquires services including disaster response planning, biohazard mitigation, data analytics for infrastructure resilience, and laboratory support for government-owned pharmaceutical and defense research initiatives, demonstrating deep expertise in high-consequence technical domains.